Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Lutronic Introduces the Most Powerful Thulium Laser to Receive FDA Clearance

The high-power 1927nm laser platform can save time with remarkable results


News provided by

Lutronic Global

Dec 03, 2019, 07:05 ET

Share this article

Share toX

Share this article

Share toX

LUTRONIC Announces the LaseMD ULTRA - The most powerful Thulium Laser to Receive FDA Clearance.
LUTRONIC Announces the LaseMD ULTRA - The most powerful Thulium Laser to Receive FDA Clearance.

BOSTON, Dec. 3, 2019 /PRNewswire-PRWeb/ --  LUTRONIC, a leading developer of intelligent energy-based medical devices, will unveil the new LaseMD ULTRA™ this week, during live patient demonstrations at the Cosmetic Surgery Forum in Nashville, Tennessee.

"Lutronic's new LaseMD ULTRA is an impressive upgrade to their already successful LaseMD®," shared Steven Weiner, M.D. "Not only is it more powerful (20 watts vs 12 watts) but it also has a significantly lower consumable cost than competitive systems. The LaseMD ULTRA offers a new larger spot size and incorporates improved 'top hat' beam profile. The system also offers an incredibly advanced graphical user interface. The integration of all the new features with real-time information helps reduce treatment time and achieve satisfying patient results in fewer treatments. Since no anesthesia is required, I can treat a full face in about 6-8 minutes or treat the face, neck and chest in 20 minutes."

“LaseMD ULTRA is my favorite new addition to my practice. It allows me to treat multiple areas quickly, effectively and for very low cost,” said Joel Cohen, M.D. “My patients love the comfortable treatments and impressive results with minimal downtime.”

Post this

The LaseMD ULTRA is yet another example of Lutronic's commitment to Intelligent Design for Intelligent Care™

  •     - Highest available power allows for fast treatments, customizable for multiple areas
  •     - Gentle, effective global improvement for all skin types, all year-round
  •     - Comfortable treatments with very little downtime
  •     - Minimal cost of ownership, easy to delegate and no shot limit per procedure

"LaseMD ULTRA is my favorite new addition to my practice. It allows me to treat multiple areas quickly, effectively and for very low cost," said Joel Cohen, M.D. "My patients love the comfortable treatments and impressive results with minimal downtime."

The LaseMD ULTRA a high-power platform which provides a full range of applications in all skin types, including:

  •     - Age spots (lentigos),
  •     - Sunspots (solar lentigos),
  •     - Freckles (ephilides),
  •     - Actinic Keratoses, and
  •     - treatment of other benign pigmented lesions.

"Customers love our original LaseMD system, so we will continue to manufacture them," said Jeff Knight, President at Lutronic. "To enhance the investments by practitioners who own our original LaseMD system, we are offering a special 'up-trade' opportunity toward a new LaseMD ULTRA platform. Sales representatives will be contacting current LaseMD owners to review the details of this offer."

This new platform will be presented at the Cosmetic Surgery Forum in Nashville, Dec. 5-7, 2019. Dr. Weiner will be performing live demonstrations of the LaseMD ULTRA on Thursday, Dec. 5 from 3-6 p.m. Please visit the Lutronic booth for more information.

Internationally, Lutronic submitted for European CE mark and Korean MFDS. Lutronic anticipates clearance in the first quarter of 2020.

To learn more about the new LaseMD ULTRA, visit: https://us.aesthetic.lutronic.com/us/products/lasemd-ultra

NOTE: Dr. Cohen and Dr. Weiner participated in Lutronic clinical trials and are paid consultants.

About LUTRONIC

Effective. Innovative. Intuitive. Dependable. These four core tenants fuel Lutronic's development of intelligent laser and energy-based systems. Committed to this mission, Lutronic partners with key opinion leaders to advance the scientific and efficacy of Lutronic's systems. To develop unrivaled systems with "smart" features, Lutronic devotes as much as four times what competitors invest in research and development, resulting in more than 535 patents and patent applications worldwide.
In addition to operations and manufacturing in the Boston area, Lutronic has a major manufacturing and research center in South Korea, offices in Germany, China, and Japan, and a worldwide network of ever-expanding direct sales teams and distributors.

©2019. LUTRONIC Group of Companies. All rights reserved. LUTRONIC, its logo, Lutronic Intelligent Care, Intelligent Design for Intelligent Care, LaseMD, and LaseMD ULTRA are trademarks or registered trademarks of the LUTRONIC Group of Companies. The LaseMD ULTRA system and its use are covered by one or more U.S. and foreign patents or patent applications pending.

SOURCE Lutronic Global

Related Links

https://us.aesthetic.lutronic.com/

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.